Abstract
A new series of 3-hydroxyquinoline derivatives 2a-c has been synthesized by decarboxylation of corresponding quinoline-4-carboxylic acid derivatives 1a-c. These 3-hydroxyquinolines have been subjected to a number of electrophilic aromatic substitution reactions (SEAr) at C4 to obtain the target structures; 3, 4, 7, 8 and 10 through: bromination, formylation, Mannich reaction, coupling with diazonium salt and acylation, respectively. In addition, formation of fused pyrano[2,3-c]quinolin-3-one 5 and chalcone 11 were done. Trials for formation of chalcone analogue 6 were failed indicating 100% of 3-hydroxy tautomer of 2a-c. All the obtained compounds can act as good chelators and contain at least 3 H-bond acceptor groups. All compounds were evaluated for antioxidant activity by ABTS assay.
Keywords: 3-Hydroxyquinolines, electrophilic aromatic substitution, antioxidant, ABTS assay.
Graphical Abstract
Letters in Organic Chemistry
Title:New Synthons of 3-Hydroxyquinoline Derivatives Through SEAr
Volume: 11 Issue: 9
Author(s): Mohammed A. M. Massoud, Serry A. El Bialy, Waleed A. Bayoumi and Walaa M. El Husseiny
Affiliation:
Keywords: 3-Hydroxyquinolines, electrophilic aromatic substitution, antioxidant, ABTS assay.
Abstract: A new series of 3-hydroxyquinoline derivatives 2a-c has been synthesized by decarboxylation of corresponding quinoline-4-carboxylic acid derivatives 1a-c. These 3-hydroxyquinolines have been subjected to a number of electrophilic aromatic substitution reactions (SEAr) at C4 to obtain the target structures; 3, 4, 7, 8 and 10 through: bromination, formylation, Mannich reaction, coupling with diazonium salt and acylation, respectively. In addition, formation of fused pyrano[2,3-c]quinolin-3-one 5 and chalcone 11 were done. Trials for formation of chalcone analogue 6 were failed indicating 100% of 3-hydroxy tautomer of 2a-c. All the obtained compounds can act as good chelators and contain at least 3 H-bond acceptor groups. All compounds were evaluated for antioxidant activity by ABTS assay.
Export Options
About this article
Cite this article as:
Massoud A. M. Mohammed, Bialy A. El Serry, Bayoumi A. Waleed and Husseiny M. El Walaa, New Synthons of 3-Hydroxyquinoline Derivatives Through SEAr, Letters in Organic Chemistry 2014; 11 (9) . https://dx.doi.org/10.2174/157017861109140903105543
DOI https://dx.doi.org/10.2174/157017861109140903105543 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Re and Tc Complexes with Pyrazolyl-Containing Chelators: from Coordination Chemistry to Target-Specific Delivery of Radioactivity
Current Radiopharmaceuticals Proteomics and Mass Spectrometry: What Have We Learned About The Heart?
Current Cardiology Reviews Modular Nanotransporters for Targeted Intracellular Delivery of Drugs: Folate Receptors as Potential Targets
Current Pharmaceutical Design Recent Advances and Challenges in Adipose Tissue Engineering: Adipose Derived Stem Cell-based Approaches
Current Tissue Engineering (Discontinued) Cell Therapies for IBD: What Works?
Current Drug Targets Hunting for Peptide Substrates of Prolyl Oligopeptidase: Classical Versus Non-Classical Bioactive Peptides
CNS & Neurological Disorders - Drug Targets Association of EGF rs4444903 and XPD rs13181 Polymorphisms with Cutaneous Melanoma in Caucasians
Medicinal Chemistry Interleukin-26, An Epitheliotropic T-Cell Cytokine
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Opportunities to Improve the Prevention and Treatment of Cervical Cancer
Current Molecular Medicine Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Current Neuropharmacology <i>Nigella sativa</i> – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare
The Natural Products Journal Overcoming Barriers to Evidence-Based Diabetes Care
Current Diabetes Reviews Immunotherapy for Multiple Sclerosis: Basic Insights for New Clinical Strategies
Current Neurovascular Research STAIR Narrative Therapy: A Skills Focused Approach to Trauma-Related Distress
Current Psychiatry Reviews Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume I)
CNS & Neurological Disorders - Drug Targets New Technologies: Non-Hormonal Female Contraception
Current Women`s Health Reviews Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders
Current Topics in Medicinal Chemistry Disturbed Sleep Patterns in Elders with Mild Cognitive Impairment: The Role of Memory Decline and ApoE ε 4 Genotype
Current Alzheimer Research Protein-Labs on Separative Analytical Scale in Medicinal Chemistry: from the Proof of Concept to Applications
Current Organic Chemistry Recent Advances in the Rationale Design of GPER Ligands
Current Medicinal Chemistry